Filtros de búsqueda

Lista de obras de Agneta Siegbahn

A Multi-Cohort Metabolomics Analysis Discloses Sphingomyelin (32:1) Levels to be Inversely Related to Incident Ischemic Stroke

scientific article published on 02 December 2019

A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score

artículo científico publicado en 2017

A detailed cardiovascular characterization of obesity without the metabolic syndrome

artículo científico publicado en 2011

A quantitative real-time PCR method for tissue factor mRNA.

artículo científico publicado en 2003

A stromal cell population in the large intestine identified by tissue factor expression that is lost during colorectal cancer progression

artículo científico publicado en 2016

ALCAM predicts future cardiovascular death in acute coronary syndromes: Insights from the PLATO trial

scientific article published on 29 November 2019

Activated partial thromboplastin time and clinical outcome after thrombin inhibition in unstable coronary artery disease

artículo científico publicado en 1999

Activated platelets provide a functional microenvironment for the antiangiogenic fragment of histidine-rich glycoprotein

artículo científico publicado en 2009

Activation of the inflammation, coagulation, and fibrinolysis systems, without influence of abciximab infusion in patients with non-ST-elevation acute coronary syndromes treated with dalteparin: a GUSTO IV substudy

artículo científico publicado en 2004

Activation of the inflammation, coagulation, and fibrinolysis systems, without influence of abciximab infusion in patients with non-ST–elevation acute coronary syndromes treated with dalteparin: a GUSTO IV substudy11Guest Editor for this manuscript

article by Stefan K James et al published February 2004 in American Heart Journal

Activation of β1 integrins and caveolin-1 by TF/FVIIa promotes IGF-1R signaling and cell survival

artículo científico publicado en 2020

Adipocytes express tissue factor and FVII and are procoagulant in a TF/FVIIa-dependent manner

artículo científico publicado en 2019

Admission Levels of DKK1 (Dickkopf-1) Are Associated With Future Cardiovascular Death in Patients With Acute Coronary Syndromes

artículo científico publicado en 2019

An acute inflammatory reaction induced by myocardial damage is superimposed on a chronic inflammation in unstable coronary artery disease

artículo científico publicado en 2005

Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation

scientific article published on 27 September 2020

Anticoagulants in heart disease: current status and perspectives

artículo científico publicado en 2007

Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis

artículo científico publicado en 2017

Antiplatelet agents for the treatment and prevention of atherothrombosis

artículo científico

Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis.

artículo científico publicado en 2018

Application of Biomarkers for Risk Stratification in Patients with Atrial Fibrillation

artículo científico publicado en 2016

Assessment of P2Y(12) inhibition with the point-of-care device VerifyNow P2Y12 in patients treated with prasugrel or clopidogrel coadministered with aspirin

artículo científico publicado en 2009

Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events

artículo científico publicado en 2019

Association of Different Estimates of Renal Function With Cardiovascular Mortality and Bleeding in Atrial Fibrillation

scientific article published on 31 August 2020

Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes: A Secondary Analysis of the PLATO Biomarker Study

scientific article published on 01 December 2018

Associations between circulating proteins and corresponding genes expressed in coronary thrombi in patients with acute myocardial infarction

artículo científico publicado en 2015

Associations between tooth loss and prognostic biomarkers and the risk for cardiovascular events in patients with stable coronary heart disease

artículo científico publicado en 2017

Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease

artículo científico publicado en 2017

Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non-ST-Elevation Acute Coronary Syndrome

artículo científico publicado en 2016

Biomarkers for risk stratification of patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention: Insights from the Platelet Inhibition and Patient Outcomes trial

artículo científico publicado en 2015

Biomarkers in atrial fibrillation: a clinical review

artículo científico

Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibi

artículo científico

Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation

artículo científico

Blood cell activation, coagulation, and inflammation in men and women with coronary artery disease

scientific article published on 01 August 2001

C-X-C Ligand 16 Is an Independent Predictor of Cardiovascular Death and Morbidity in Acute Coronary Syndromes

scientific article published on 26 September 2019

C-reactive protein and e-selectin levels are related to vasodilation in resistance, but not conductance arteries in the elderly: the prospective investigation of the Vasculature in Uppsala Seniors (PIVUS) study

artículo científico publicado en 2007

C5a receptor expression on leukocytes from patients with severe sepsis or septic shock

CRP and IL-6 concentrations are associated with poor glycemic control despite preserved beta-cell function during the first year after diagnosis of type 1 diabetes

artículo científico publicado en 2004

Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy

artículo científico publicado en 2012

Cardiac troponin is associated with cardiac outcomes in men and women with atrial fibrillation, insights from the ARISTOTLE trial

scientific article published on 30 April 2020

Carotid Endarterectomy Induces the Release of Inflammatory Markers and the Activation of Coagulation as Measured in the Jugular Bulb

artículo científico publicado en 2017

Cell adhesion and tissue factor upregulation in oxygenators used during coronary artery bypass grafting are modified by the Corline Heparin Surface

scientific article published on 01 December 2002

Circulating cell-derived microparticles as biomarkers in cardiovascular disease

artículo científico publicado en 2016

Clinical and Pharmacological Effects of Apixaban Dose Adjustment in the ARISTOTLE Trial

artículo científico publicado en 2020

Coagulation, fibrinolysis, and cell activation in patients and shed mediastinal blood during coronary artery bypass grafting with a new heparin-coated surface

artículo científico publicado en 2002

Common variants associated with plasma triglycerides and risk for coronary artery disease

artículo científico publicado en 2013

Comparison of Cardiac Troponins I and T Measured with High-Sensitivity Methods for Evaluation of Prognosis in Atrial Fibrillation: An ARISTOTLE Substudy

Cross-talk between the Tissue Factor/coagulation factor VIIa complex and the tyrosine kinase receptor EphA2 in cancer

artículo científico publicado en 2016

Cystatin C and estimated glomerular filtration rate as predictors for adverse outcome in patients with ST-elevation and non-ST-elevation acute coronary syndromes: results from the Platelet Inhibition and Patient Outcomes study

artículo científico publicado en 2011

Cystatin C- and creatinine-based estimates of renal function and their value for risk prediction in patients with acute coronary syndrome: results from the PLATelet Inhibition and Patient Outcomes (PLATO) study

artículo científico publicado en 2013

D-dimer and factor VIIa in atrial fibrillation - prognostic values for cardiovascular events and effects of anticoagulation therapy. A RE-LY substudy.

artículo científico publicado en 2016

D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation--observations from the ARISTOTLE trial

artículo científico publicado en 2014

Dabigatran etexilate and reduction in serum apolipoprotein B

artículo científico publicado en 2015

Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial

artículo científico publicado en 2011

Discovery and refinement of loci associated with lipid levels

artículo científico publicado en 2013

Discovery of New Risk Markers for Ischemic Stroke Using a Novel Targeted Proteomics Chip

artículo científico publicado en 2015

Early decrease in coagulation activity after myocardial infarction is associated with lower risk of new ischaemic events: observations from the ESTEEM Trial

artículo científico publicado en 2007

Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation

scientific article published on 12 September 2018

Effect of genetic variations on ticagrelor plasma levels and clinical outcomes

artículo científico publicado en 2015

Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation in Relation to Renal Function Over Time: Insights From the ARISTOTLE Randomized Clinical Trial

artículo científico

Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) trial analysis

artículo científico

Enhanced platelet activation mediates the accelerated angiogenic switch in mice lacking histidine-rich glycoprotein

scientific journal article

Evaluation of microparticles in whole blood by multicolour flow cytometry assay

artículo científico publicado en 2013

Evaluation of the Age, Biomarkers, and Clinical History-Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials

scientific article published on 01 September 2020

Expression of fibrinolytic and coagulation factors in cocultured human endothelial and smooth muscle cells

artículo científico publicado en 2004

Extracellular vesicles in atrial fibrillation and stroke

artículo científico publicado en 2020

Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy ⬇️

artículo científico publicado en 2018

GDF-15 and TRAIL-R2 are powerful predictors of long-term mortality in patients with acute myocardial infarction

artículo científico publicado en 2017

GDF-15 for prognostication of cardiovascular and cancer morbidity and mortality in men

artículo científico publicado en 2013

General mechanisms of coagulation and targets of anticoagulants (Section I). Position Paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease.

artículo científico publicado en 2013

Genetic determinants of dabigatran plasma levels and their relation to bleeding

artículo científico publicado en 2013

Genetic determinants of warfarin maintenance dose and time in therapeutic treatment range: a RE-LY genomics substudy

artículo científico publicado en 2016

Genetic variation in the interleukin-6 gene in relation to risk and outcomes in acute coronary syndrome

scientific article published on 16 June 2006

Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease

artículo científico publicado en 2009

Genetic variations in the tissue factor gene are associated with clinical outcome in acute coronary syndrome and expression levels in human monocytes

artículo científico publicado en 2005

Genetically determined height and coronary artery disease

artículo científico publicado en 2015

Genome-Wide Association Study Identifies That the ABO Blood Group System Influences Interleukin-10 Levels and the Risk of Clinical Events in Patients with Acute Coronary Syndrome

artículo científico publicado en 2015

Genome-wide association and Mendelian randomization study of NT-proBNP in patients with acute coronary syndrome

artículo científico publicado en 2016

Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals

artículo científico publicado en 2020

Greater reduction of platelet activation markers and platelet-monocyte aggregates by prasugrel compared to clopidogrel in stable coronary artery disease

scientific article published on 01 October 2008

Growth Differentiation Factor 15 Predicts All-Cause Morbidity and Mortality in Stable Coronary Heart Disease

artículo científico publicado en 2016

Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major Bleeding

artículo científico publicado en 2017

Growth Differentiation Factor 15 for Risk Stratification and Selection of an Invasive Treatment Strategy in Non ST-Elevation Acute Coronary Syndrome

article by K. C. Wollert et al published 2 October 2007 in Circulation

Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARI

artículo científico

Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study

artículo científico publicado en 2015

Growth-differentiation factor 15 and risk of major bleeding in atrial fibrillation: Insights from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial

artículo científico publicado en 2017

Growth-differentiation factor-15 for long-term risk prediction in patients stabilized after an episode of non-ST-segment-elevation acute coronary syndrome

scientific article published on 11 December 2009

HRG regulates tumor progression, epithelial to mesenchymal transition and metastasis via platelet-induced signaling in the pre-tumorigenic microenvironment

artículo científico publicado en 2013

Heparin-coated cardiopulmonary bypass circuits reduce circulating complement factors and interleukin-6 in paediatric heart surgery

scientific article published on 01 January 2000

High-sensitive cardiac troponin T and its relations to cardiovascular risk factors, morbidity, and mortality in elderly men.

artículo científico publicado en 2013

High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial

artículo científico publicado en 2013

High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin

artículo científico publicado en 2013

How to use D-dimer in acute cardiovascular care

artículo científico

IL-33 stimulates the release of procoagulant microvesicles from human monocytes and differentially increases tissue factor in human monocyte subsets

artículo científico publicado en 2017

Identification of novel downstream molecules of tissue factor activation by comparative proteomic analysis

artículo científico publicado en 2013

Impact of physical activity on cardiovascular status in obesity

artículo científico publicado en 2016

Impaired Fibrinolysis Predicts Adverse Outcome in Acute Coronary Syndrome Patients with Diabetes: A PLATO Sub-Study

artículo científico publicado en 2020

Importance of persistent elevation of cardiac biomarkers in atrial fibrillation: a RE-LY substudy

artículo científico publicado en 2014

Improved identification of patients with coronary artery disease by the use of new lipid and lipoprotein biomarkers

artículo científico publicado en 2006

Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial

artículo científico publicado en 2017

Influence on coagulation activity by subcutaneous LMW heparin as an adjuvant treatment to fibrinolysis in acute myocardial infarction

artículo científico publicado en 2002

Interleukin-18 in patients with acute coronary syndromes

artículo científico publicado en 2019

Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation

artículo científico publicado en 2015

Large-scale association analysis identifies new risk loci for coronary artery disease

artículo científico publicado en 2012

Large-scale metabolomic profiling identifies novel biomarkers for incident coronary heart disease

artículo científico publicado en 2014

Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease

artículo científico publicado en 2016

Lipoprotein-associated phospholipase A2 does not predict mortality or new ischaemic events in acute coronary syndrome patients

artículo científico publicado en 2007

Long-term treatment with ximelagatran, an oral direct thrombin inhibitor, persistently reduces the coagulation activity after a myocardial infarction

artículo científico publicado en 2005

Low molecular weight dextran sulfate: a strong candidate drug to block IBMIR in clinical islet transplantation

artículo científico publicado en 2006

Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction—the ASSENT Plus study ⬇️

artículo científico publicado el 1 de mayo de 2003

Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study

artículo científico publicado en 2013

Methylation-based estimated biological age and cardiovascular disease

artículo científico publicado en 2017

Microparticles during long-term follow-up after acute myocardial infarction. Association to atherosclerotic burden and risk of cardiovascular events

artículo científico publicado en 2017

Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation: Response to Luo and Bu

artículo científico publicado en 2022

Myocardial damage, coagulation activity and the response to thrombin inhibition in unstable coronary artery disease

artículo científico publicado en 2004

N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).

artículo científico publicado en 2013

N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arte

artículo científico publicado en 2003

N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease

artículo científico publicado en 2003

NLRC4 Inflammasome Is an Important Regulator of Interleukin-18 Levels in Patients With Acute Coronary Syndromes: Genome-Wide Association Study in the PLATelet inhibition and patient Outcomes Trial (PLATO).

artículo científico publicado en 2015

New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper

artículo científico publicado en 2012

Niemann-Pick C1 modulates hepatic triglyceride metabolism and its genetic variation contributes to serum triglyceride levels

artículo científico publicado en 2010

No benefit of reduced heparinization in thoracic aortic operation with heparin-coated bypass circuits

artículo científico publicado en 2000

Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel

artículo científico publicado en 2014

Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial

article published in 2018

Oral anticoagulants in coronary heart disease (Section IV). Position paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease

artículo científico publicado en 2016

Osteoprotegerin Is Associated With Major Bleeding But Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes: Insights From the PLATO (Platelet Inhibition and Patient Outcomes) Trial

artículo científico publicado en 2018

Outcome and causes of renal deterioration evaluated by serial cystatin C measurements in acute coronary syndrome patients—Results from the PLATelet inhibition and patient Outcomes (PLATO) study

scientific article published on 17 October 2012

Outcomes after planned invasive or conservative treatment strategy in patients with non-ST-elevation acute coronary syndrome and a normal value of high sensitivity troponin at randomisation: A Platelet Inhibition and Patient Outcomes (PLATO) trial b

artículo científico publicado en 2016

Oxidized low-density lipoprotein as a predictor of outcome in patients with unstable coronary artery disease

artículo científico publicado en 2005

PML/RARalpha plays a role for basal activity and retinoid-induced repression of the tissue factor promoter in acute promyelocytic leukemia cells

scientific article published on 01 November 2003

Parenteral anticoagulants in heart disease: current status and perspectives (Section II). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease

artículo científico publicado en 2013

Patients with poor responsiveness to thienopyridine treatment or with diabetes have lower levels of circulating active metabolite, but their platelets respond normally to active metabolite added ex vivo

artículo científico publicado en 2008

Pentraxin-3 vs C-reactive protein and other prognostic biomarkers in acute coronary syndrome: A substudy of the Platelet Inhibition and Patients Outcomes (PLATO) trial

scientific article published on 24 April 2019

Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation

artículo científico

Plasminogen activator inhibitor-1 activity is independently related to both insulin sensitivity and serum triglycerides in 70-year-old men.

artículo científico publicado en 1998

Platelet inhibition assessed with VerifyNow, flow cytometry and PlateletMapping in patients undergoing heart surgery.

artículo científico publicado en 2009

Platelet-related biomarkers and their response to inhibition with aspirin and p2y12-receptor antagonists in patients with acute coronary syndrome.

artículo científico

Platelet-specific PDGFB ablation impairs tumor vessel integrity and promotes metastasis

scientific article published on 25 June 2020

Polymorphism of the cystatin C gene in patients with acute coronary syndromes: Results from the PLATelet inhibition and patient Outcomes study

article

Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease

artículo científico publicado en 2007

Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease

artículo científico publicado en 2006

Prediction of Residual Risk by Ceramide-Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical Therapy

artículo científico publicado en 2020

Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the PLATelet inhibition and patient Outcomes (PLATO) trial

artículo científico publicado en 2019

Prognosis in unstable coronary artery disease. Multimarker strategy is the best basis for the therapeutic choice

artículo científico publicado en 2004

Prognostic impact of baseline inflammatory markers in patients with acute coronary syndromes treated with ticagrelor and clopidogrel

scientific article published on 23 December 2019

ProteinSeq: high-performance proteomic analyses by proximity ligation and next generation sequencing

artículo científico publicado en 2011

Proteomic Biomarkers for Incident Aortic Stenosis Requiring Valvular Replacement.

artículo científico publicado en 2018

Raised interleukin-10 is an indicator of poor outcome and enhanced systemic inflammation in patients with acute coronary syndrome

artículo científico publicado en 2008

Regulation of chemotaxis by the cytoplasmic domain of tissue factor

scientific article published on 01 January 2005

Relations of growth-differentiation factor-15 to biomarkers reflecting vascular pathologies in a population-based sample of elderly subjects

artículo científico publicado en 2011

Relationship between clopidogrel-induced platelet P2Y12 inhibition and stent thrombosis or myocardial infarction after percutaneous coronary intervention-a case-control study

artículo científico publicado en 2011

Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy

artículo científico publicado en 2001

Response to letter regarding article, "Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a randomized evaluation of long-term anticoagulation therapy (RE-LY) substudy".

artículo científico publicado en 2013

Response to letter regarding article, "Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial a

artículo científico publicado en 2014

Risk Markers of Incident Atrial Fibrillation in Patients with Coronary Heart Disease

scientific article published on 02 January 2021

Role and analysis of monocyte subsets in cardiovascular disease. Joint consensus document of the European Society of Cardiology (ESC) Working Groups "Atherosclerosis & Vascular Biology" and "Thrombosis".

artículo científico publicado en 2016

Role of Extracellular Vesicles in Pulmonary Arterial Hypertension: Modulation of Pulmonary Endothelial Function and Angiogenesis

artículo científico publicado en 2020

Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation

scientific article published on 09 December 2020

Sensitive and Specific Detection of Platelet-Derived and Tissue Factor-Positive Extracellular Vesicles in Plasma Using Solid-Phase Proximity Ligation Assay

scientific article published on 27 July 2018

Sensitive plasma protein analysis by microparticle-based proximity ligation assays

artículo científico publicado en 2009

Serial measurement of interleukin-6 and risk of mortality in anticoagulated patients with atrial fibrillation: Insights from ARISTOTLE and RE-LY trials

artículo científico publicado en 2020

Simvastatin induces apoptosis in human breast cancer cells in a NFkappaB-dependent manner and abolishes the anti-apoptotic signaling of TF/FVIIa and TF/FVIIa/FXa

artículo científico publicado en 2007

Simvastatin reduces the production of prothrombotic prostasomes in human prostate cancer cells.

artículo científico publicado en 2008

Soluble CD40L levels are regulated by the -3459 A>G polymorphism and predict myocardial infarction and the efficacy of antithrombotic treatment in non-ST elevation acute coronary syndrome

artículo científico publicado en 2006

Subsequent Event Risk in Individuals With Established Coronary Heart Disease

artículo científico publicado en 2019

TF/FVIIa transactivate PDGFRbeta to regulate PDGF-BB-induced chemotaxis in different cell types: involvement of Src and PLC

artículo científico publicado en 2008

The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation

artículo científico publicado en 2016

The ABC risk score for patients with atrial fibrillation - Authors' reply.

artículo científico publicado en 2016

The Eph tyrosine kinase receptors EphB2 and EphA2 are novel proteolytic substrates of tissue factor/coagulation factor VIIa

artículo científico publicado en 2014

The composition and daily variation of microparticles in whole blood in stable coronary artery disease.

artículo científico publicado en 2015

The effect of a low molecular mass thrombin inhibitor, inogatran, and heparin on thrombin generation and fibrin turnover in patients with unstable coronary artery disease

artículo científico publicado en 1999

The influence of different heparin surface concentrations and antithrombin-binding capacity on inflammation and coagulation

artículo científico publicado en 2005

The influence of direct thrombin inhibitors on the formation of platelet-leukocyte aggregates and tissue factor expression

artículo científico publicado en 2010

The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study.

artículo científico publicado en 2016

The platelet inhibiting effect of a clopidogrel bolus dose in patients on long-term acetylsalicylic acid treatment

artículo científico publicado en 2007

The utility of coagulation activity for prediction of risk of mortality and cardiovascular events in guideline-treated myocardial infarction patients

artículo científico publicado en 2017

Thrombo-Inflammation in Cardiovascular Disease: An Expert Consensus Document from the Third Maastricht Consensus Conference on Thrombosis

scientific article published on 14 April 2020

Tissue Factor Noncoagulant Signaling: Mechanisms and Implications for Cell Migration and Apoptosis

artículo científico

Tissue Factor/ FVIIa prevents the extrinsic pathway of apoptosis by regulation of the tumor suppressor Death-Associated Protein Kinase 1 (DAPK1).

artículo científico publicado en 2010

Tissue factor and IL8 production by P-selectin-dependent platelet-monocyte aggregates in whole blood involves phosphorylation of Lyn and is inhibited by IL10

artículo científico publicado en 2008

Tissue factor in ulcerative colitis, with and without concomitant primary sclerosing cholangitis

scientific article published on 27 November 2019

Tissue factor non-coagulant signaling - molecular mechanisms and biological consequences with a focus on cell migration and apoptosis.

artículo científico

Tissue factor regulation and cytokine expression in monocyte-endothelial cell co-cultures: effects of a statin, an ACE-inhibitor and a low-molecular-weight heparin

artículo científico publicado en 2002

Tissue factor/factor VIIa induces cell survival and gene transcription by transactivation of the insulin-like growth factor 1 receptor.

artículo científico publicado en 2013

Tissue factor/factor VIIa signalling promotes cytokine-induced beta cell death and impairs glucose-stimulated insulin secretion from human pancreatic islets

artículo científico publicado en 2015

Treatment with an oral direct thrombin inhibitor decreases platelet activity but increases markers of inflammation in patients with myocardial infarction ⬇️

artículo científico publicado el 23 de febrero de 2011

Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy

artículo científico publicado en 2003

Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy

artículo científico publicado en 2006

Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation

artículo científico publicado en 2018

Use of a proximity extension assay proteomics chip to discover new biomarkers for human atherosclerosis

artículo científico publicado en 2015

Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (a GUSTO IV substudy).

artículo científico publicado en 2005

Variants of the Interferon Regulatory Factor 5 Gene Regulate Expression of IRF5 mRNA in Atherosclerotic Tissue But Are Not Associated With Myocardial Infarction

article

Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease

scientific article published on 14 November 2013

Xa inhibition and coagulation activity--the influence of prolonged dalteparin treatment and gender in patients with acute coronary syndrome and healthy individuals

artículo científico publicado en 2008

[Prophylaxis of postoperative thromboembolism. New alternatives to low-molecular-weight heparin]

scientific article published on 01 July 2002

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda